Functional inhibition of CCR3‐dependent responses by peptides derived from phage libraries

So far chemokine antagonists have been identified by modification of the NH2‐terminus of known chemokines or by screening large number of compounds in functional assays. Here we used phage display peptide libraries to identify hexapeptides that antagonize the interaction between eotaxin and its receptor CCR3. The peptide sequence CPWYFWPC was recovered by panning phage libraries on CCR3‐transfected murine pre‐B cells after elution with eotaxin. The synthetic, structurally constrained peptide effectively competed 125I‐eotaxin binding to CCR3 (IC50 = 20 μM). Furthermore, it had weak agonistic effects on Ca2+ mobilization in CCR3 transfectants that underwent heterologous desensitization by subsequent exposure to eotaxin. The peptide inhibited chemotaxis of CCR3 transfectants induced by a broad panel of CCR3 ligands. Specificity was tested with the CXCR1, CXCR2, CXCR3 and CCR5 receptors. In experiments aimed at characterization of residues necessary for eotaxin binding, we affinity purified the linear eotaxin‐binding peptide VTPRQR, and showed that the peptide displaced the binding of radiolabeled eotaxin to CCR3 (IC50 = 300 μM) ina dose‐dependent manner, inhibited eotaxin induced increases in intracellular Ca2+, and migration of CCR3‐transfected cells. Specificity was affirmed using other CCR3 ligands. This is the first de novo identification of chemokine antagonists by direct screening on target proteins.

[1]  M. Baggiolini,et al.  The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3* , 2001, The Journal of Biological Chemistry.

[2]  H. Sarau,et al.  Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration* , 2000, The Journal of Biological Chemistry.

[3]  E. Fernandez,et al.  Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation. , 2000, Biochemistry.

[4]  M. Stone,et al.  Characterization of binding between the chemokine eotaxin and peptides derived from the chemokine receptor CCR3. , 2000, The Journal of biological chemistry.

[5]  M. Peck,et al.  A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3 , 2000, The Journal of Biological Chemistry.

[6]  M. Manns,et al.  Allergy and the Gut , 2000, International Archives of Allergy and Immunology.

[7]  M. Horwitz,et al.  Regulation of the NF-κB Activation Pathway by Isolated Domains of FIP3/IKKγ, a Component of the IκB-α Kinase Complex* , 2000, The Journal of Biological Chemistry.

[8]  A. Balic,et al.  Do eosinophils have a role in the killing of helminth parasites? , 2000, Parasitology today.

[9]  B. Nardelli,et al.  C-C Chemokine Receptor 3 Antagonism by the β-Chemokine Macrophage Inflammatory Protein 4, a Property Strongly Enhanced by an Amino-Terminal Alanine-Methionine Swap1 , 2000, The Journal of Immunology.

[10]  M. Humbert,et al.  Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. , 1999, Journal of immunology.

[11]  F. Annunziato,et al.  Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. , 1999, The American journal of pathology.

[12]  J. Mach,et al.  New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries. , 1999, European journal of biochemistry.

[13]  S. Bel,et al.  Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. , 1999, Journal of immunology.

[14]  Durham,et al.  The inflammatory nature of allergic disease , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  S. Durham Mechanisms of mucosal inflammation in the nose and lungs. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  C. Mackay,et al.  Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils , 1997, Current Biology.

[17]  M. Baggiolini,et al.  Blocking Chemokine Receptors , 1997, The Journal of experimental medicine.

[18]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[19]  C. Mackay,et al.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. , 1997, The Journal of clinical investigation.

[20]  N. Skelton,et al.  Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5. , 1997, Biochemistry.

[21]  T. Schwartz,et al.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.

[22]  P. Leder,et al.  Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.

[23]  C. Mackay,et al.  Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. , 1997, The Journal of clinical investigation.

[24]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[25]  Ronald W. Barrett,et al.  Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.

[26]  J. H. Butler,et al.  High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Montjovent,et al.  Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*) , 1996, The Journal of Biological Chemistry.

[28]  S. Miller,et al.  Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils , 1995, The Journal of cell biology.

[29]  L. Lichtenstein,et al.  Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. , 1994, The Journal of allergy and clinical immunology.

[30]  W. DeGrado,et al.  Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library , 1992, Proteins.

[31]  R. Aebersold,et al.  Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide. , 1991, Biochemistry.

[32]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[33]  M. Baggiolini,et al.  Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration , 1986, Nature.